These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7873131

  • 1. Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumors.
    Pirker W, Brücke T, Riedl M, Clodi M, Luger A, Asenbaum S, Podreka I, Deecke L.
    J Neural Transm Gen Sect; 1994; 97(3):235-44. PubMed ID: 7873131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T.
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [Abstract] [Full Text] [Related]

  • 6. Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    de Herder WW, Reijs AE, de Swart J, Kaandorp Y, Lamberts SW, Krenning EP, Kwekkeboom DJ.
    Eur J Nucl Med; 1999 Jan; 26(1):46-50. PubMed ID: 9933661
    [Abstract] [Full Text] [Related]

  • 7. In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.
    Scillitani A, Dicembrino F, Di Fazio P, Vettori PP, D'Angelo V, Scarabino T, Liuzzi A.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2523-5. PubMed ID: 7629253
    [Abstract] [Full Text] [Related]

  • 8. Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.
    Verhoeff NP, Bemelman FJ, Wiersinga WM, van Royen EA.
    Eur J Nucl Med; 1993 Jun; 20(6):555-61. PubMed ID: 8339737
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic imaging of dopamine receptors in pituitary adenomas.
    de Herder WW, Reijs AEM, Feelders RA, van Aken MO, Krenning EP, van der Lely AJ, Kwekkeboom DJ.
    Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S53-S56. PubMed ID: 17413189
    [Abstract] [Full Text] [Related]

  • 10. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
    Ferone D, Pivonello R, Lastoria S, Faggiano A, Del Basso de Caro ML, Cappabianca P, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):469-77. PubMed ID: 11318782
    [Abstract] [Full Text] [Related]

  • 11. Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?
    de Herder WW, Reijs AE, Feelders RA, van Aken MO, Krenning EP, Tanghe HL, van der Lely AJ, Kwekkeboom DJ.
    Eur J Endocrinol; 2006 Nov; 155(5):717-23. PubMed ID: 17062888
    [Abstract] [Full Text] [Related]

  • 12. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J, Castelli L, Cordes M, Schelosky L, Poewe W, Felix R.
    Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
    [Abstract] [Full Text] [Related]

  • 13. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
    Bolko P, Jaskuła M, Waśko R, Wołuń M, Sowiński J.
    Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
    [Abstract] [Full Text] [Related]

  • 14. [Clinical application of 11C-NMSP to the patients with pituitary adenoma other than prolactinoma].
    Momose T, Teramoto A, Nishikawa J, Inoue Y, Watanabe T, Sasaki Y.
    Kaku Igaku; 1993 Jun; 30(6):627-35. PubMed ID: 8345693
    [Abstract] [Full Text] [Related]

  • 15. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Schwarz J, Tatsch K, Gasser T, Arnold G, Oertel WH.
    Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212
    [Abstract] [Full Text] [Related]

  • 16. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
    Reiche W, Grundmann M, Huber G.
    Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
    [Abstract] [Full Text] [Related]

  • 17. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R, Schulte KW, Vosberg H, Ruzicka T, Müller-Gärtner HW.
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C, Scholz SW, Donnemiller E, Decristoforo C, Oberladstätter M, Stefanova N, Diederen E, Virgolini I, Poewe W, Wenning GK.
    Neuroimage; 2005 Feb 01; 24(3):822-31. PubMed ID: 15652317
    [Abstract] [Full Text] [Related]

  • 19. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M, Krack P, Franz M, Klett R, Bauer R, Gallhofer B, Dorndorf W.
    Mov Disord; 1996 Nov 01; 11(6):726-8. PubMed ID: 8914102
    [Abstract] [Full Text] [Related]

  • 20. Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma.
    Del Gatto V, Bima C, Chiloiro S, Giampietro A, Bianchi A.
    Endocrine; 2018 Jun 01; 60(3):532-534. PubMed ID: 29214441
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.